STERIS plc (STE)
| Previous close | 215.16 |
| Open | 215.36 |
| Bid | 215.20 x 800 |
| Ask | 215.67 x 1000 |
| Day's range | 212.60 - 217.50 |
| 52-week range | 170.36 - 248.30 |
| Volume | |
| Avg. volume | 456,027 |
| Market cap | 21.585B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | 78.47 |
| EPS (TTM) | 2.75 |
| Earnings date | 08 Feb 2022 |
| Forward dividend & yield | 1.72 (0.80%) |
| Ex-dividend date | 22 Nov 2021 |
| 1y target est | 258.00 |
- GlobeNewswire
STERIS to Host a Conference Call for Fiscal 2022 Third Quarter Financial Results on February 9, 2022
DUBLIN, IRELAND, Jan. 25, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 third quarter financial results at 10:00 a.m. ET on February 9, 2022. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing third quarter
- Zacks
Steris (STE) Earnings Expected to Grow: Should You Buy?
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
STERIS (STE) to Report Q3 Earnings: What's in the Cards?
The ongoing integration of Cantel Medical business and robust demand from medical device customers are expected to have contributed to STERIS' (STE) Q3 performance.
